Security key
005083100
ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share (ACTU)
CUSIP: 005083100
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, par value $0.000001 per share
- Total 13F shares
- 382,167
- Total 13F value
- $2,847,155
- Share change
- +382,167
- SEC-reported price per share
- $7.45
- Number of holders
- 10
- Value change
- +$2,847,155
- Number of buys
- 10
- Shares outstanding
- 23,561,857
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
10
Top holders
10
ACTU full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
ACTUATE THERAPEUTICS, INC. SEC filings
ACTUATE THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 005083100
Recent filing periods:
Ownership snapshot
Top reported holders of ACTU - ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Bios Clinical Opportunity...
Disclosed value leader
—
Comparable rows
0/2
Latest evidence
14 Aug 2024
3/4/5
Some rows are evidence-backed but not safely comparable across classes.
2 rows are not safely comparable across share classes.
Quick read
SEC ownership evidence is available, but the rows are not safely comparable across share classes.
0 of 2 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Bios Clinical Opportunity Fund, LP's linked filing trail.
Detailed SEC evidence table Showing 1-2 of 2 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Bios Clinical Opportunity Fund, LP |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
231,377 shares
|
— | 12 Aug 2024 |
| Bios 2024 Co-Invest, LP |
3/4/5
Director, Member of 10% Group
|
—
class O/S missing
|
—
125,000 shares
|
— | 14 Aug 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
382,167
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q4 2025 Across Filers
Q4 2025 holders
44
Q3 2024 holders
10
Holder diff
-34
| Investor | Q4 2025 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q4 2025 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend